Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell …
M Uzunel, J Mattsson, M Brune… - Blood, The Journal …, 2003 - ashpublications.org
The kinetics of minimal residual disease (MRD) and chimerism were studied in 15 patients
with chronic myeloid leukemia (CML) receiving nonmyeloablative stem cell transplantation …
with chronic myeloid leukemia (CML) receiving nonmyeloablative stem cell transplantation …
[PDF][PDF] Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell …
M Uzunel, J Mattsson, M Brune, JE Johansson… - BLOOD, 2003 - Citeseer
Allogeneic hematopoietic stem cell transplantation (SCT) is the treatment of choice for
patients with chronic myeloid leukemia (CML) who have a suitable donor. 1 In older patients …
patients with chronic myeloid leukemia (CML) who have a suitable donor. 1 In older patients …
Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell …
M Uzunel, J Mattsson, M Brune, JE Johansson… - Blood, 2002 - europepmc.org
The kinetics of minimal residual disease (MRD) and chimerism were studied in 15 patients
with chronic myeloid leukemia (CML) receiving nonmyeloablative stem cell transplantation …
with chronic myeloid leukemia (CML) receiving nonmyeloablative stem cell transplantation …
Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell …
M Uzunel, J Mattsson, M Brune, JE Johansson… - …, 2003 - pubmed.ncbi.nlm.nih.gov
The kinetics of minimal residual disease (MRD) and chimerism were studied in 15 patients
with chronic myeloid leukemia (CML) receiving nonmyeloablative stem cell transplantation …
with chronic myeloid leukemia (CML) receiving nonmyeloablative stem cell transplantation …
[HTML][HTML] Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell …
M Uzunel, J Mattsson, M Brune, JE Johansson… - Blood, 2003 - Elsevier
The kinetics of minimal residual disease (MRD) and chimerism were studied in 15 patients
with chronic myeloid leukemia (CML) receiving nonmyeloablative stem cell transplantation …
with chronic myeloid leukemia (CML) receiving nonmyeloablative stem cell transplantation …
[PDF][PDF] Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell …
M Uzunel, J Mattsson, M Brune, JE Johansson… - BLOOD, 2003 - researchgate.net
Allogeneic hematopoietic stem cell transplantation (SCT) is the treatment of choice for
patients with chronic myeloid leukemia (CML) who have a suitable donor. 1 In older patients …
patients with chronic myeloid leukemia (CML) who have a suitable donor. 1 In older patients …
[引用][C] Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell …
M UZUNEL - Blood, 2003 - cir.nii.ac.jp
Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia
after nonmyeloablative conditioning and allogeneic stem cell transplantation | CiNii Research …
after nonmyeloablative conditioning and allogeneic stem cell transplantation | CiNii Research …
[引用][C] Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell …
M UZUNEL, J MATTSSON, M BRUNE… - Blood, 2003 - pascal-francis.inist.fr
Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia
after nonmyeloablative conditioning and allogeneic stem cell transplantation CNRS Inist …
after nonmyeloablative conditioning and allogeneic stem cell transplantation CNRS Inist …